Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Florida Biologix Expands Capacity | Contract Pharma

What are you searching for?

Sign in
Breaking News

Florida Biologix Expands Capacity

Florida Biologix has expanded its production and fill capacity for high-quality protein production and aseptic filling for Phase I/II clinical trial materials.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Florida Biologix has expanded its production and fill capacity for high-quality protein production and aseptic filling for Phase I/II clinical trial materials.

The company will now offer GMP protein production (MAbs, recombinant proteins or subunit vaccines) up to 400L scale with the addition of a new Sartorius BIOSTAT CultiBag STR200 Plus Twin stirred-tank disposable bioreactor. Also, a new 10L BIOSTAT B-DCU in its 5,000-sq.-ft. process development labs allows for scale-up from development to GMP manufacturing.

The company has also expanded its class 1000 fill suite and can now perform automated aseptic fills up to 5,000 vials/batch, increasing previous capacity by 70%. The company fills a variety of containers ranging from 0.1 milliliters to 3 Liters.

Florida Biologix director, Dr. Richard Snyder, said, “This expansion underscores our commitment to continue to meet the needs of our clients who appreciate how we are able to find cost-effective solutions for their clinical projects, overcome difficult technical challenges and deliver released products on-time.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics